XML 39 R19.htm IDEA: XBRL DOCUMENT
v3.10.0.1

Employee Stock and Benefit Plans | 12 Months Ended
--- | ---
Sep. 30, 2018
Disclosure of Compensation Related Costs, Share-based Payments [Abstract] |
Employee Stock and Benefit Plans | Employee Stock and Benefit Plans We maintain several equity incentive plans under which we may grant non-qualified stock options, incentive stock options, restricted stock, restricted stock units (“RSUs”) or stock appreciation rights to employees, non-employee directors and consultants. We issue new shares of common stock upon exercise of stock options and the vesting of RSUs. We also have an employee stock purchase plan (“ESPP”). As of September 30, 2018, there were 56.9 million shares of common stock available for issuance pursuant to future equity-based compensation awards and 12.7 million shares available for issuance under our ESPP. Stock-based compensation expense recognized in the consolidated financial statements (in millions):
Fiscal Year Ended | Sep 30, 2018 |  | Oct 1, 2017 |  | Oct 2, 2016
Options | $ | 28.0 |  |  | $ | 44.3 |  |  | $ | 42.7 |
RSUs | 222.3 |  |  | 131.7 |  |  | 175.4 |
Total stock-based compensation expense recognized in the consolidated statements of earnings | $ | 250.3 |  |  | $ | 176.0 |  |  | $ | 218.1 |
Total related tax benefit | $ | 62.4 |  |  | $ | 57.6 |  |  | $ | 73.0 |
Total capitalized stock-based compensation included in net property, plant and equipment and inventories on the consolidated balance sheets | $ | 3.5 |  |  | $ | 1.9 |  |  | $ | 1.5 |
Stock Option Plans Stock options to purchase our common stock are granted at the fair value of the stock on the grant date. The majority of options become exercisable in four equal installments beginning a year from the grant date and generally expire 10 years from the grant date. Options granted to non-employee directors generally vest over one to three years. All outstanding stock options are non-qualified stock options. The fair value of stock option awards was estimated at the grant date with the following weighted average assumptions for fiscal years 2018, 2017 and 2016:
| Employee Stock Options Granted During the Period
Fiscal Year Ended | 2018 |  | 2017 |  | 2016
Expected term (in years) | 3.6 |  |  | 3.9 |  |  | 3.9 |
Expected stock price volatility | 20.5 | % |  | 21.6 | % |  | 23.9 | %
Risk-free interest rate | 2.1 | % |  | 1.5 | % |  | 1.2 | %
Expected dividend yield | 2.2 | % |  | 1.8 | % |  | 1.3 | %
Weighted average grant price | $ | 56.56 |  |  | $ | 56.12 |  |  | $ | 60.20 |
Estimated fair value per option granted | $ | 7.32 |  |  | $ | 8.56 |  |  | $ | 10.54 |
The expected term of the options represents the estimated period of time until exercise and is based on historical experience of similar awards, giving consideration to the contractual terms, vesting schedules and expectations of future employee behavior. Expected stock price volatility is based on a combination of historical volatility of our stock and the one-year implied volatility of Starbucks traded options, for the related vesting periods. The risk-free interest rate is based on the implied yield available on U.S. Treasury zero-coupon issues with an equivalent remaining term. The dividend yield assumption is based on our anticipated cash dividend payouts. The amounts shown above for the estimated fair value per option granted are before the estimated effect of forfeitures, which reduce the amount of expense recorded in the consolidated statements of earnings. Stock option transactions for the year ended September 30, 2018 (in millions, except per share and contractual life amounts):
| Shares Subject to Options |  | Weighted Average Exercise Price per Share |  | Weighted Average Remaining Contractual Life (Years) |  | Aggregate Intrinsic Value
Outstanding, October 1, 2017 | 31.4 |  |  | $ | 36.51 |  |  | 5.8 |  | $ | 589 |
Granted | 3.9 |  |  | 56.56 |  |  |  |  |
Exercised | (6.3 | ) |  | 19.46 |  |  |  |  |
Expired/forfeited | (1.7 | ) |  | 55.24 |  |  |  |  |
Outstanding, September 30, 2018 | 27.3 |  |  | 42.13 |  |  | 5.2 |  | 418 |
Exercisable, September 30, 2018 | 19.8 |  |  | 36.95 |  |  | 4.1 |  | 405 |
Vested and expected to vest, September 30, 2018 | 26.3 |  |  | 41.59 |  |  | 5.1 |  | 417 |
The aggregate intrinsic value in the table above, which is the amount by which the market value of the underlying stock exceeded the exercise price of outstanding options, is before applicable income taxes and represents the amount optionees would have realized if all in-the-money options had been exercised on the last business day of the period indicated. As of September 30, 2018, total unrecognized stock-based compensation expense, net of estimated forfeitures, related to nonvested options was approximately $19 million, before income taxes, and is expected to be recognized over a weighted average period of approximately 2.4 years. The total intrinsic value of options exercised was $236 million, $181 million, and $254 million during fiscal years 2018, 2017 and 2016, respectively. The total fair value of options vested was $53 million, $40 million, and $37 million during fiscal years 2018, 2017 and 2016, respectively. RSUs We have both time-vested and performance-based RSUs. Time-vested RSUs are awarded to eligible employees and non-employee directors and entitle the grantee to receive shares of common stock at the end of a vesting period, subject solely to the employee’s continuing employment or the non-employee director's continuing service. The majority of time-vested RSUs vest in two equal annual installments beginning a year from the grant date. Our performance-based RSUs are awarded to eligible employees and entitle the grantee to receive shares of common stock if we achieve specified performance goals during the performance period and the grantee remains employed during the subsequent vesting period. The majority of performance-based RSUs vest in two equal annual installments beginning two years from the grant date. RSU transactions for the year ended September 30, 2018 (in millions, except per share and contractual life amounts):
| Number of Shares |  | Weighted Average Grant Date Fair Value per Share |  | Weighted Average Remaining Contractual Life (Years) |  | Aggregate Intrinsic Value
Nonvested, October 1, 2017 | 7.6 |  |  | $ | 52.06 |  |  | 0.9 |  | $ | 410 |
Granted | 9.5 |  |  | 56.48 |  |  |  |  |
Vested | (3.3 | ) |  | 50.18 |  |  |  |  |
Forfeited/canceled | (2.6 | ) |  | 54.87 |  |  |  |  |
Nonvested, September 30, 2018 | 11.2 |  |  | 55.62 |  |  | 1.0 |  | 636 |
For fiscal 2017 and 2016, the weighted average fair value per RSU granted was $54.30 and $58.81, respectively. As of September 30, 2018, total unrecogniz ed stock-based compensation expense related to nonvested RSUs, net of estimated forfeitures, was approximately $192 million, before income taxes, and is expected to be recognized over a weighted average period of approximately 1.9 years. The total fair value of RSUs vested was $166 million, $182 million and $169 million during fiscal years 2018, 2017 and 2016, respectively. ESPP Our ESPP allows eligible employees to contribute up to 10% of their base earnings toward the quarterly purchase of our common stock, subject to an annual maximum dollar amount. The purchase price is 95% of the fair market value of the stock on the last business day of the quarterly offering period. The number of shares issued under our ESPP was 0.6 million in fiscal 2018. Deferred Compensation Plan We have a Deferred Compensation Plan for Non-Employee Directors under which non-employee directors may, for any fiscal year, irrevocably elect to defer receipt of shares of common stock the director would have received upon vesting of restricted stock units. The number of deferred shares outstanding related to deferrals made under this plan is not material. Defined Contribution Plans We maintain voluntary defined contribution plans, both qualified and non-qualified, covering eligible employees as defined in the plan documents. Participating employees may elect to defer and contribute a portion of their eligible compensation to the plans up to limits stated in the plan documents, not to exceed the dollar amounts set by applicable laws. Our matching contributions to all U.S. and non-U.S. plans were $111.7 million, $101.4 million and $86.2 million in fiscal years 2018, 2017 and 2016, respectively.

X
- Definition The entire disclosure for compensation-related costs for equity-based compensation, which may include disclosure of policies, compensation plan details, allocation of equity compensation, incentive distributions, equity-based arrangements to obtain goods and services, deferred compensation arrangements, employee stock ownership plan details and employee stock purchase plan details. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -URI http://asc.fasb.org/topic&trid=2228938 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 50 -URI http://asc.fasb.org/subtopic&trid=2208855 + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration